All Stories

  1. Combining multiset resolution and segmentation for hyperspectral image analysis of biological tissues
  2. Benchmark datasets for 3D MALDI- and DESI-imaging mass spectrometry
  3. Formation of a biocompatible protein corona on magnetic nanoparticles
  4. MALDI mass spectrometric imaging meets “omics”: recent advances in the fruitful marriage
  5. Spatial Segmentation of MALDI FT-ICR MSI Data: A Powerful Tool to Explore the Head and Neck Tumor In Situ Lipidome
  6. Proteomic Effects of the Coagulation Proteinase Thrombin on LX-2 Hepatic Stellate Cells
  7. The search for the primary tumor in metastasized gastroenteropancreatic neuroendocrine neoplasm
  8. Histomolecular interpretation of pleomorphic adenomas of the salivary gland by matrix-assisted laser desorption ionization imaging and spatial segmentation
  9. 910 Urine protein profiling identified alpha-1-microglobulin and haptoglobin as biomarkers for early diagnosis of acute allograft rejection following kidney transplantation
  10. PD30-08 URINE PROTEIN PROFILING IDENTIFIED ALPHA-1-MICROGLOBULIN AND HAPTOGLOBIN AS BIOMARKERS FOR EARLY DIAGNOSIS OF ACUTE ALLOGRAFT REJECTION FOLLOWING KIDNEY TRANSPLANTATION
  11. Urine protein profiling identified alpha-1-microglobulin and haptoglobin as biomarkers for early diagnosis of acute allograft rejection following kidney transplantation
  12. Analysis and Interpretation of Imaging Mass Spectrometry Data by Clustering Mass-to-Charge Images According to Their Spatial Similarity
  13. A Novel Multiplex–Protein Array for Serum Diagnostics of Colorectal Cancer: Impact of Pre-analytical Storage Conditions
  14. Deeper Understanding of Biological Tissue: Quantitative Correlation of MALDI-TOF and Raman Imaging
  15. SELDI-TOF analysis of glioblastoma cyst fluid is an approach for assessing cellular protein expression
  16. Transthyretin Is Dysregulated in Preeclampsia, and Its Native Form Prevents the Onset of Disease in a Preclinical Mouse Model
  17. Multimodal nonlinear microscopic investigations on head and neck squamous cell carcinoma: Toward intraoperative imaging
  18. A novel multiplex-protein array for serum diagnostics of colon cancer: a case–control study
  19. MALDI-imaging segmentation is a powerful tool for spatial functional proteomic analysis of human larynx carcinoma
  20. MALDI-Imaging: What can be expected?
  21. 2134 DIFFERENCES IN PROTEIN PROPERTIES OF POSTOPERATIVE URINE SAMPLES ENABLE THE PREDICTION OF EARLY ALLOGRAFT REJECTION
  22. Monitoring the morphochemistry of laryngeal carcinoma by multimodal imaging
  23. 210 Differences in protein properties of postoperative urine samples enable the prediction of early allograft rejection
  24. 315 Prediction of TKI-therapy response in patients with metastatic renal cell carcinoma by serum proteomics
  25. Homozygous CFTR mutation M348K in a boy with respiratory symptoms and failure to thrive. Disease-causing mutation or benign alteration?
  26. Toward Standardized High-Throughput Serum Diagnostics
  27. Specific Protein Patterns Characterize Metastatic Potential of Advanced Bladder Cancer
  28. Localization of sporadic neuroendocrine tumors by gene expression analysis of their metastases
  29. Combinatorial Optimization of Multiple MALDI Matrices on a Single Tissue Sample Using Inkjet Printing
  30. 2251 PROTEIN SIGNATURE IN URINE INDICATES REJECTION AFTER KIDNEY TRANSPLANTATION AT AN EARLY POSTOPERATIVE STATE
  31. Chromosome 5 derived small supernumerary marker: towards a genotype/phenotype correlation of proximal chromosome 5 imbalances
  32. Is There a Yet Unreported Unbalanced Chromosomal Abnormality without Phenotypic Consequences in Proximal 4p?
  33. Spatial Segmentation of Imaging Mass Spectrometry Data with Edge-Preserving Image Denoising and Clustering
  34. Confirmation of the biological significance of transthyretin as a biomarker for cutaneous T-cell lymphoma by its protein interaction partners
  35. Depicting the Spatial Distribution of Proteins in Human Tumor Tissue Combining SELDI and MALDI Imaging and Immunohistochemistry
  36. Immunochemotherapy-associated protein patterns in tumour tissue and serum of patients with metastatic renal cell carcinoma
  37. Specific protein and miRNA patterns characterise tumour-associated fibroblasts in bladder cancer
  38. Disruption of ALX1 Causes Extreme Microphthalmia and Severe Facial Clefting: Expanding the Spectrum of Autosomal-Recessive ALX-Related Frontonasal Dysplasia
  39. 98 TKI THERAPY RELATED PROTEOMIC PATTERNS IN SERUM FROM PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
  40. 722 SPECIFIC PROTEIN PATTERNS CHARACTERIZE METASTATIC POTENTIAL IN ADVANCED BLADDER CANCER
  41. 1793 TKI THERAPY RELATED PROTEOMIC PATTERNS IN SERUM FROM PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
  42. 204 A SPECIFIC PROTEIN SIGNATURE CHARACTERIZES THE METASTATIC POTENTIAL OF CLEAR CELL RENAL CELL CARCINOMAS
  43. Small Supernumerary Marker Chromosomes 1 With a Normal Phenotype
  44. Comparative proteomic analysis of normal and tumor stromal cells by tissue on chip based mass spectrometry (toc-MS)
  45. Derivative chromosome 1 and GLUT1 deficiency syndrome in a sibling pair
  46. Proteomic analysis of microdissected facial nuclei of the rat following facial nerve injury
  47. Periphilin is a novel interactor of synphilin-1, a protein implicated in Parkinson's disease
  48. New Approaches to Analyze Follicular Fluids
  49. Regulation of the anaphase-promoting complex by the COP9 signalosome
  50. Annexin A5 is involved in migration and invasion of oral carcinoma
  51. Proteomic analysis of human papillomavirus-related oral squamous cell carcinoma: Identification of thioredoxin and epidermal-fatty acid binding protein as upregulated protein markers in microdissected tumor tissue
  52. Clinically abnormal case with paternally derived partial trisomy 8p23.3 to 8p12 including maternal isodisomy of 8p23.3: a case report
  53. Colon-Derived Liver Metastasis, Colorectal Carcinoma, and Hepatocellular Carcinoma Can Be Discriminated by the Ca2+-Binding Proteins S100A6 and S100A11
  54. Surface Enhanced Laser Desorption and Ionisation (SELDI) Massenspektrometrie zur Untersuchung von Follikel-Flüssigkeit
  55. Protein profiling of single epidermal cell types from Arabidopsis thaliana using surface-enhanced laser desorption and ionization technology
  56. Tapping an unexploited repository: Carnoy's fixed cell pellets for proteomic biomarker research in leukemia
  57. Complex chromosomal rearrangements associated with congenital erythrophagocytotic histiocytosis
  58. Rad54B Targeting to DNA Double-Strand Break Repair Sites Requires Complex Formation with S100A11
  59. IDENTIFICATION OF SPECIFIC PROTEIN PATTERNS IN TUMOUR TISSUE FOR PREDICTION OF IMMUNE-CHEMOTHERAPY RESPONSE
  60. Parental-origin-determination fluorescence in situ hybridization distinguishes homologous human chromosomes on a single-cell level
  61. Human Neutrophil Peptides 1-3 – Early Markers in Development of Colorectal Adenomas and Carcinomas
  62. Diagnostik des oralen Plattenepithelkarzinoms und seiner Präkursorläsionen
  63. Diagnosis of oral squamous cell carcinoma and its precursor lesions
  64. The Tumor Suppressors p33ING1 and p33ING2 Interact with Alien in Vivo and Enhance Alien-Mediated Gene Silencing
  65. Protein-Mikroarrays
  66. Alien inhibits E2F1 gene expression and cell proliferation
  67. Identifizierung von Rejektionsmarkern nach Nierentransplantation mit Hilfe der Proteinchiptechnologie
  68. Microdissecting the proteome
  69. Microdissected tissue: an underestimated source for biomarker discovery?
  70. Investigation of human embryo-conditioned IVF culture medium through the use of surface enhanced laser desorption and ionization (SELDI) mass spectrometry
  71. Interactions of TANGO and leukocyte integrin CD11c/CD18 regulate the migration of human monocytes
  72. Cytogenetic characterisation and proteomic profiling of the Imatinib-resistant cell line KCL22-R
  73. Definition spezifischer Proteinmuster für fortgeschrittene (metastasierte) Harnblasentumoren zur individuellen Prognosebestimmung und Therapiewahl
  74. The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein—implications for Parkinson’s disease
  75. Molecular cytogenetic characterization of eight small supernumerary marker chromosomes originating from chromosomes 2, 4, 8,18, and 21 in three patients
  76. Protein profiling of oral brush biopsies: S100A8 and S100A9 can differentiate between normal, premalignant, and tumor cells
  77. Detection and Identification of Transcription Factors as Interaction Partners of Alien in vivo
  78. Protein Profiling of Microdissected Pancreas Carcinoma and Identification of HSP27 as a Potential Serum Marker
  79. Posttranslational Modifications of Transthyretin Are Serum Markers in Patients with Mycosis Fungoides
  80. 40 IMMUNE ESCAPE IN RENAL CELL CARCINOMAS BY CD70 MEDIATED APOPTOSIS IN T-LYMPHOCYTES?
  81. Various Members of the E2F Transcription Factor Family Interact in vivo with the Corepressor Alien
  82. 448 IDENTIFICATION OF SERUM AMYLOID ALPHA AND TRANSTHYRETIN AS BIOMARKERS FOR CLEAR CELL RENAL CELL CARCINOMAS
  83. New Immortalized Cell Lines of Patients With Small Supernumerary Marker Chromosome
  84. Specific pattern of protein expression in acute myeloid leukemia harboring FLT3-ITD mutations
  85. Orale Zytologie
  86. Region-specific alterations of global protein expression in the remodelled rat myocardium
  87. The Prognostic Relevance of p16 Inactivation in Head and Neck Cancer
  88. Comparative transcriptional and functional profiling of clear cell and papillary renal cell carcinoma
  89. IDENTIFICATION OF BIOMARKERS IN SERUM FROM RENAL CELL CANCER PATIENTS BY PROTEINCHIP-TECHNOLOGY
  90. 1141644472 Surface Enhanced Laser Desorption and Ionization (SELDI) mass spectrometry for investigation of human embryo conditioned IVF culture medium
  91. Protein Profiles of Bronchoalveolar Lavage Fluid from Patients with Pulmonary Sarcoidosis
  92. Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling
  93. Convergence of the proteomic pattern in cancer
  94. Identifizierung von Biomarkern und therapeutischen Targets beim Nierenzellkarzinom mittels ProteinChip-Technologie
  95. Identification of HNP3 as a tumour marker in CD4+ and CD4− lymphocytes of patients with cutaneous T-cell lymphoma
  96. Different expression of calgizzarin (S100A11) in normal colonic epithelium, adenoma and colorectal carcinoma
  97. Is there a higher incidence of maternal uniparental disomy 14 [upd(14)mat]? Detection of 10 new patients by methylation-specific PCR
  98. Small supernumerary marker chromosomes – progress towards a genotype-phenotype correlation
  99. Detection and Identification of Protein Interactions of S100 Proteins by ProteinChip Technology
  100. Characterization of Pepsinogen C as a Potential Biomarker for Gastric Cancer Using a Histo-Proteomic Approach
  101. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry
  102. Identification of proteins from colorectal cancer tissue by two-dimensional gel electrophoresis and SELDI mass spectrometry
  103. Discovery and Identification of α-Defensins as Low Abundant, Tumor-Derived Serum Markers in Colorectal Cancer
  104. ProteinChip Technology Reveals Distinctive Protein Expression Profiles in the Urine of Bladder Cancer Patients
  105. Prader–Willi syndrome with a karyotype 47,XY,+min(15)(pter->q11.1:) and maternal UPD 15—case report plus review of similar cases
  106. 65 Detection and differentiation of bladder cancer in urine by proteinchip-technology
  107. 505CD70- a new tumour specific biomarker for renal cell carcinoma
  108. Identification of protein pattern in kidney cancer using ProteinChip® arrays and bioinformatics
  109. Molecular cytogenetic characterization of a de novo supernumerary ring chromosome 7 resulting in partial trisomy, tetrasomy, and hexasomy in a child with dysmorphic signs, congenital heart defect, and developmental delay
  110. Identification of Sex Hormone-Binding Globulin in the Human Hypothalamus
  111. Untersuchungen zum Einfluss der Inaktivierung des Tumorsupressorgenes p16 auf die Prognose von Plattenepithelkarzinomen der Kopf-Hals-Region
  112. Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip® technology
  113. ProteinChip System Technology: A Powerful Tool to Analyze Expression Differences in Tissue-Engineered Blood Vessels
  114. Small supernumerary marker chromosomes (SMCs): genotype-phenotype correlation and classification
  115. Biomarker Discovery by Tissue Microdissectionand ProteinChipR Array Analysis. Identifizierung von Biomarkern uber Gewebemikrodissektionund ProteinChipR Array Analyse
  116. Proteome analysis in kidney cancer using a new combination of protein chip and maldi-tof technology
  117. Biomarker Discovery by Tissue Microdissection and ProteinChip® Array Analysis/Identifizierung von Biomarkern über Gewebemikrodissektion und ProteinChip® Array Analyse
  118. Supernumerary small marker chromosome (SMC) and uniparental disomy 22 in a child with confined placental mosaicism of trisomy 22: Trisomy rescue due to marker chromosome formation
  119. First patient with trisomy 21 accompanied by an additional der(4)(:p11 ? q11:) plus partial uniparental disomy 4p15-16
  120. Cultivation of fetal erythroid precursors from maternal blood: Isolation and characterization by PCR and FISH
  121. Maternal uniparental disomy 12 in a healthy girl with a 47,XX,+der(12)(:p11->q11:)/46,XX karyotype
  122. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers
  123. Fluorescent dual colour 2D-protein gel electrophoresis for rapid detection of differences in protein pattern with standard image analysis software
  124. Mass spectrometry meets chip technology: A new proteomic tool in cancer research?
  125. Tetrasomy 21 due to a de novo Robertsonian translocation t(14;21) and an additional free trisomy 21
  126. A long distance-PCR derived FISH probe detects a deletion between p15 and p16 in CML and T-ALL patients
  127. Maternal UPD 20 in an infant from a pregnancy with mosaic trisomy 20
  128. How to Enrich and Analyze Fetal Cells from Maternal Blood: 5-Year Experience with PCR, FISH and Cultivation
  129. Applicability of Four New Antibodies for the Detection of Fetal Nucleated Cells Out of Maternal Blood by FISH Analysis
  130. P53 genotyping - an effective concept for molecular testing of head and neck cancer?
  131. Tumor suppressor gene p16 (CDKN2A) mutation status and promoter inactivation in head and neck cancer.
  132. Determination of the origin of single nucleated cells in maternal circulation by means of random PCR and a set of length polymorphisms
  133. Rapid detection of trisomy 21 by quantitative PCR
  134. Structure determination of c()Cs/Rh(100) by LEED
  135. Detection and Identification of TAA by SELDI-TOF
  136. Optical Methods